Shenzhen Glory Medical Co.,Ltd. (SHE:002551)
China · Delayed Price · Currency is CNY 3.750
-0.050 (-1.32%)
Feb 13, 2026, 3:04 PM CST
Shenzhen Glory Medical Revenue
Shenzhen Glory Medical had revenue of 225.48M CNY in the quarter ending September 30, 2025, a decrease of -39.25%. This brings the company's revenue in the last twelve months to 1.20B, down -6.08% year-over-year. In the year 2024, Shenzhen Glory Medical had annual revenue of 1.45B with 21.40% growth.
Revenue (ttm)
1.20B
Revenue Growth
-6.08%
P/S Ratio
2.64
Revenue / Employee
850.42K
Employees
1,410
Market Cap
3.17B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.45B | 255.32M | 21.40% |
| Dec 31, 2023 | 1.19B | -82.82M | -6.49% |
| Jan 1, 2023 | 1.28B | -514.59M | -28.74% |
| Jan 1, 2022 | 1.79B | -477.00M | -21.04% |
| Dec 31, 2020 | 2.27B | 736.47M | 48.11% |
| Jan 1, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Pharmaceuticals Holding | 280.69B |
| Jointown Pharmaceutical Group | 157.71B |
| C.Q. Pharmaceutical Holding | 83.08B |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company | 77.54B |
| China National Accord Medicines Corporation | 73.04B |
| China National Medicines Corporation | 51.95B |
| China Meheco Group | 33.23B |
| Guangxi LiuYao Group | 20.95B |